Contralateral prophylactic mastectomy associated with survival in select breast cancer patients
EurekAlert!
Contact: Laura Sussman lsussman@mdanderson.org
713-745-2457
University of Texas M. D. Anderson Cancer Center
Public release date: 25-Feb-2010
First large, population-based study to find an association between procedure and survival; findings offer data for women making difficult, personal decision
"Rare" cancers in the spotlight at major European conference - ESMO Conference on Sarcoma and GIST
ESMO: European Society for Medical Oncology
26/02/2010
More should be done across Europe to ensure that people with rare forms of cancer are not denied access to the best possible treatment, say the organizers of a major European cancer conference to be held in Milan on 9 and 10 March 2010.
Proton beam therapy shows encouraging long-term outcome for patients with locally advanced sinonasal cancers
EurekAlert!
Contact: Beth Bukata bethb@astro.org
703-431-2332
American Society for Radiation Oncology
Proton beam radiation therapy shows encouraging results for patients with locally advanced sinonasal malignancies, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO...
Sunesis Poised for Phase 3 Trial of Voreloxin in Acute Myeloid Leukemia After Completing Formal End-of-Phase 2 Meetings With FDA
Company on Track to Initiate Pivotal Study in Second Half of 2010
CNNMoney.com
Source: Marketwire
February 25, 2010: 07:30 AM ET
Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) today announced that it has completed formal End-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA) related to its lead compound,...
Pretreatment SUV associated with head and neck cancer treatment outcomes, may help decide treatment plans
EurekAlert!
Public release date: 25-Feb-2010
Contact: Beth Bukata bethb@astro.org
703-431-2332
Source: American Society for Radiation Oncology
The maximal standardized uptake value (called SUVmax) measured from FDG PET readings taken from the primary tumor in head and necksquamous cell carcinoma patients before treatment is a strong...
